Zymeworks Inc.

ZYMENASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
28.37 USD
↗ 0.15 (0.53%)AT CLOSE (03:59 PM EDT)
28.39
↗ 0.02 (0.05%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
28.39
↗ 0.02 (0.05%)
🔴Market: CLOSED

ZYME is currently priced at $28.38. ZYME shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Strong Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Oct 26, 2026.

Open?$28.36
High?$28.59
Low?$27.59
Prev. Close?$28.22
Volume?833.9K
Avg. Volume?1.2M
VWAP?$28.04
Rel. Volume?0.71x
Bid / Ask
Bid?$25.60 × 200
Ask?$29.00 × 200
Spread?$3.40
Midpoint?$27.30
Valuation & Ratios
Market Cap?2.0B
Shares Out?71.0M
Float?42.8M
Float %?60.3%
P/E Ratio?N/A
P/B Ratio?25.19
EPS?-$2.09
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
Themes
Healthcare - Oncology›Targeted Therapy & Precision OncologyBiotech - Drug Development›Clinical-Stage Platforms
Employees
264
Market Cap
2.0B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.zymeworks.com
Listed
2017-04-28
Address
108 PATRIOT DRIVE, SUITE A
MIDDLETOWN, DE 19709
Phone: 302-274-8744
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookStrong Sell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
1
Momentum?
3
Short Sent.?
35
Piotroski F-Score?1/9Weak
Altman Z-Score?-0.73Distress
Confidence?73%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?13.04%High
Short Interest?5.6M
Days to Cover?4.4
Free Float42.8M
Avg Daily Volume1.3M
Settlement Date2026-10-15
Financial Health
Current Ratio?6.32Strong
Quick Ratio?6.32Strong
Cash Ratio?3.80Strong
Debt/Equity?0.00Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
50/100
P/E?
N/A▾
P/B?
Peers
100
S&P
3
25.19HIGH▾
P/S?
Peers
100
S&P
3
54.54HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-12.3CHEAP▾
EV/Sales?
Peers
100
S&P
3
49.70HIGH▾
Returns & Efficiency
ROE?
S&P
3
-186.6%WEAK▾
ROA?
S&P
3
-37.8%WEAK▾
Cash Flow & Enterprise
FCF?$-120544000
Enterprise Value?$1.8B
Fundamentals ratios updated end of day
MarketsMoversWatchlist